JOSE MANUEL RUBIN LOPEZ-rekin lankidetzan egindako argitalpenak (7)

2022

  1. KCNH2 p.Gly262AlafsTer98: A New Threatening Variant Associated with Long QT Syndrome in a Spanish Cohort

    Life, Vol. 12, Núm. 4

2019

  1. Spectral analysis of the QT interval increases the prediction accuracy of clinical variables in Brugada syndrome

    Journal of Clinical Medicine, Vol. 8, Núm. 10

2018

  1. Role of syncope in predicting adverse outcomes in patients with suspected Brugada syndrome undergoing standardized flecainide testing

    Europace, Vol. 20, Núm. FI1, pp. f64-f71

2017

  1. Differential methylation of lncRNA KCNQ1OT1 promoter polymorphism was associated with symptomatic cardiac long QT

    Epigenomics, Vol. 9, Núm. 8, pp. 1049-1057

2016

  1. Surveillance after cardiac arrest in patients with Brugada syndrome without an implantable defibrillator: An alarm effect of the previous syncope

    International Journal of Cardiology, Vol. 218, pp. 69-74

2015

  1. Time-dependent responses to provocative testing with flecainide in the diagnosis of Brugada syndrome

    Heart Rhythm, Vol. 12, Núm. 2, pp. 350-357

2010

  1. Espectro mutacional del gen SCN5A en pacientes españoles con síndrome de Brugada

    Revista Espanola de Cardiologia, Vol. 63, Núm. 7, pp. 856-859